BioSpace News Archive

Cartography Biosciences today announced the appointment of Dan Rock, Ph.D., as Chief Scientific Officer.

Oragenics, Inc. announced that its engagement agreement with its investment bank has expired and that it does not intend to extend the engagement at this time due to market conditions.

MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the publication of extensive work describing preclinical studies for lead candidate THIO in small cell lung cancer (SCLC) in the peer-reviewed scientific journal Nature Communications.

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”)(Nasdaq: BDRX) today announced that the U.S. Patent and Trademark Office allowed U.S. patent application No. 16/546,595 titled “Prevention of Pancreatic Cell Degeneration” which was exclusively licensed to Biodexa by Melior Pharmaceuticals, Inc., along with other patents, in a transaction which closed in December 2023.

Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference.

Standard BioTools Inc. announced a collaboration agreement with Navignostics AG for development of clinical research applications and service offerings using the Hyperion XTi™ Imaging System.

Nanalysis Scientific Corp., a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that Founder and CEO Sane Krakiwsky will be participating in an upcoming webinar and conference.

Cardio Diagnostics Holdings, Inc. announced that the Company’s AI-driven epigenetic-genetic blood tests, Epi+Gen CHD and PrecisionCHD, will be available beginning Q2 2024 in a retail healthcare setting inside the Walmart Supercenter in Round Lake Beach, Illinois.

More than two-thirds of patients with hepatocellular carcinoma, who receive surgical interventions, experience recurrence owing to lack of an established perioperative treatment.

Complete Genomics and seqWell announced a partnership aimed at expanding the range of library preparation product offerings available to Complete Genomics customers.